Advertisement
Financing › Details
Pontifax–SEVERAL: investment, 201710–201801 closing $240m of new fifth fund
Record changed: 2018-01-05 |
Advertisement
More documents for Pontifax (Group)
- [1] Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen....
- [2] Emergence Therapeutics AG. (12/7/21). "Press Release: Emergence Therapeutics Raises €87 Million Series A Financing to Advance Nectin-4 ADC". Duisburg....
- [3] Agomab Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent....
- [4] Keros Therapeutics, Inc.. (1/7/19). "Press Release: Keros Therapeutics Receives $23 Million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases". Lexington, MA....
- [5] ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona....
- [6] Orbach, Meir [CalcalisTech]. (1/1/18). "News: Pontifax Raises a $240 Million Fifth Fund. Life Sciences-focused Venture Capital Firm Pontifax Is Expected to Invest Most of the New Fund in the Pharmaceutical Industry"....
- [7] Step Pharma S.A.S.. (11/21/17). "Press Release: Step Pharma Completes €14.5 million Series A Financing with Additional New Investor". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top